Senior Neuromuscular Clinical Sales Leader

Sarepta Therapeutics; Topeka (KS); Hybrid; USD 173,000 - 217,000; Full time

Benefits offered by this job

Physical and Emotional Wellness

Financial Wellness

Support for Caregivers

Job summary

Sarepta Therapeutics is seeking a Sr. Neuromuscular Clinical Sales Specialist to promote therapies to medical providers across a US territory. This role requires meeting enrollment goals, understanding market dynamics, and collaborating with a matrix team to improve patient access and outcomes.

The candidate will be responsible for building referral networks, educating physicians on genetic testing and assay access, and developing strategic account plans. Travel up to 70% is expected.

Qualifications

• 7+ years of field experience in biotech, preferably in orphan diseases.
• Neuromuscular or pediatric neurology experience preferred.
• Excellent consultative selling skills with proven performance.
• Ability to travel up to 70%.

Responsibilities

• Promote Sarepta therapies to medical providers within assigned US territory.
• Drive enrollment form attainment and educate on product labeling and policies.
• Build and maintain referral networks with physicians' offices and hospitals.
• Develop strategic account plans and ensure coverage of geography.
• Lead HCP education on genetic testing, access, and assay.
• Collaborate with cross-functional teams to meet customer needs and ensure compliance.

Skills

Consultative selling

Verbal and written communication

Relationship building

Education

Bachelor's Degree

Tools

MS Office Suite

Veeva/Salesforce

Job description

Sarepta Therapeutics is seeking a Sr. Neuromuscular Clinical Sales Specialist to promote therapies to medical providers across a US territory. This role requires meeting enrollment goals, understanding market dynamics, and collaborating with a matrix team to improve patient access and outcomes.

The candidate will be responsible for building referral networks, educating physicians on genetic testing and assay access, and developing strategic account plans. Travel up to 70% is expected.